140 related articles for article (PubMed ID: 29578881)
1. Aggressive Digital Papillary Adenocarcinoma: Population-Based Analysis of Incidence, Demographics, Treatment, and Outcomes.
Rismiller K; Knackstedt TJ
Dermatol Surg; 2018 Jul; 44(7):911-917. PubMed ID: 29578881
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence and survival of eccrine malignancies in the United States: A SEER population-based study.
Tripathi R; Ezaldein HH; Scott JF; Bordeaux JS
J Am Acad Dermatol; 2019 Jun; 80(6):1769-1771. PubMed ID: 30287321
[No Abstract] [Full Text] [Related]
3. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
4. Aggressive digital papillary adenocarcinoma: A clinicopathological study of 19 cases.
Weingertner N; Gressel A; Battistella M; Cribier B
J Am Acad Dermatol; 2017 Sep; 77(3):549-558.e1. PubMed ID: 28495496
[TBL] [Abstract][Full Text] [Related]
5. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
6. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited).
Duke WH; Sherrod TT; Lupton GP
Am J Surg Pathol; 2000 Jun; 24(6):775-84. PubMed ID: 10843279
[TBL] [Abstract][Full Text] [Related]
7. Head and neck sweat gland adenocarcinoma: A population-based perspective of a rare entity.
Unsal AA; Patel VR; Chung SY; Zhou AH; Baredes S; Eloy JA
Laryngoscope; 2017 Dec; 127(12):2757-2762. PubMed ID: 28397272
[TBL] [Abstract][Full Text] [Related]
8. Highly variable clinical feature and course of aggressive digital papillary adenocarcinoma.
Yokota K; Kono M; Shimizu K; Sakakibara A; Akiyama M
J Dermatol; 2018 Mar; 45(3):357-360. PubMed ID: 29194742
[TBL] [Abstract][Full Text] [Related]
9. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
J Cutan Pathol; 1987 Jun; 14(3):129-46. PubMed ID: 3301927
[TBL] [Abstract][Full Text] [Related]
10. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma.
Feldmeyer L; Prieto VG; Ivan D; Nagarajan P; Tetzlaff MT; Curry JL; Bell D; Moon BS; Torres-Cabala CA; Aung PP
Ann Clin Lab Sci; 2016; 46(2):222-4. PubMed ID: 27098633
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma.
Surowy HM; Giesen AK; Otte J; Büttner R; Falkenstein D; Friedl H; Meier F; Petzsch P; Wachtmeister T; Westphal D; Wieczorek D; Wruck W; Adjaye J; Rütten A; Redler S
Br J Dermatol; 2019 May; 180(5):1150-1160. PubMed ID: 30472730
[TBL] [Abstract][Full Text] [Related]
12. Aggressive Digital Papillary Adenocarcinoma: Case Report of a Positive Sentinel Lymph Node and Discussion of Utility of Sentinel Lymph Node Biopsy.
Kempton SJ; Navarrete AD; Salyapongse AN
Ann Plast Surg; 2015 Jul; 75(1):34-6. PubMed ID: 25954845
[TBL] [Abstract][Full Text] [Related]
13. Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature.
Knackstedt RW; Knackstedt TJ; Findley AB; Piliang M; Jellinek NJ; Bernard SL; Vidimos A
Int J Dermatol; 2017 Oct; 56(10):1061-1064. PubMed ID: 28832985
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
15. Digital papillary adenoma (ADPA) and aggressive digital papillary adenocarcinoma (AdPACa).
Gorva AD
Am J Dermatopathol; 2005 Dec; 27(6):546-7; author reply 547. PubMed ID: 16314709
[No Abstract] [Full Text] [Related]
16. Aggressive digital papillary adenocarcinoma: a case report and review of the literature.
Jih DM; Elenitsas R; Vittorio CC; Berkowitz AR; Seykora JT
Am J Dermatopathol; 2001 Apr; 23(2):154-7. PubMed ID: 11285414
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors, Treatment, and Survival in Primary Cutaneous Mucinous Carcinoma: A SEER Database Analysis.
Rismiller KP; Crowe DR; Knackstedt TJ
Dermatol Surg; 2020 Sep; 46(9):1141-1147. PubMed ID: 31702595
[TBL] [Abstract][Full Text] [Related]
18. Metastatic aggressive digital papillary adenocarcinoma.
Altman CE; Hamill RL; Elston DM
Cutis; 2003 Aug; 72(2):145-7. PubMed ID: 12953940
[TBL] [Abstract][Full Text] [Related]
19. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
Avraham JB; Villines D; Maker VK; August C; Maker AV
J Surg Oncol; 2013 Jul; 108(1):57-62. PubMed ID: 23677677
[TBL] [Abstract][Full Text] [Related]
20. Malignant eccrine neoplasms of the foot.
Pontone M; Potter GK; Berlin SJ; Reiss PA; Levin RS; Mantell GM; Gleitman D; Kennelty JM; Simon SD; Kahn JB
J Foot Ankle Surg; 1994; 33(5):486-91. PubMed ID: 7849675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
